Ghent University Academic Bibliography

Advanced

The von Hippel-Lindau tumor suppressor gene expression level has prognostic value in neuroblastoma

Jasmien Hoebeeck UGent, Jo Vandesompele UGent, Helén Nisson, Katleen De Preter UGent, Nadine Van Roy UGent, Els De Smet UGent, Nurten Yigit UGent, Anne De Paepe UGent, Genevieve Laureys UGent and Sven Påhlman, et al. (2006) INTERNATIONAL JOURNAL OF CANCER. 119(3). p.624-629
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
EMBRYOGENESIS, 3p-deletion, HETEROZYGOSITY, VHL, CELLS, PROTEIN, DIFFERENTIATION, PCR, CGH ANALYSIS, HIPPEL-LINDAU-DISEASE, COMPARATIVE GENOMIC HYBRIDIZATION, hypoxia, survival, neuroblastoma, VHL (von Hippel-Lindau)
journal title
INTERNATIONAL JOURNAL OF CANCER
Int. J. Cancer
volume
119
issue
3
pages
624 - 629
Web of Science type
Article
Web of Science id
000238476800020
JCR category
ONCOLOGY
JCR impact factor
4.693 (2006)
JCR rank
27/125 (2006)
JCR quartile
1 (2006)
ISSN
0020-7136
DOI
10.1002/ijc.21888
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
364328
handle
http://hdl.handle.net/1854/LU-364328
date created
2007-02-28 16:34:00
date last changed
2010-08-09 10:35:12
@article{364328,
  author       = {Hoebeeck, Jasmien and Vandesompele, Jo and Nisson, Hel{\'e}n and De Preter, Katleen and Van Roy, Nadine and De Smet, Els and Yigit, Nurten and De Paepe, Anne and Laureys, Genevieve and P{\aa}hlman, Sven and Speleman, Franki},
  issn         = {0020-7136},
  journal      = {INTERNATIONAL JOURNAL OF CANCER},
  keyword      = {EMBRYOGENESIS,3p-deletion,HETEROZYGOSITY,VHL,CELLS,PROTEIN,DIFFERENTIATION,PCR,CGH ANALYSIS,HIPPEL-LINDAU-DISEASE,COMPARATIVE GENOMIC HYBRIDIZATION,hypoxia,survival,neuroblastoma,VHL (von Hippel-Lindau)},
  language     = {eng},
  number       = {3},
  pages        = {624--629},
  title        = {The von Hippel-Lindau tumor suppressor gene expression level has prognostic value in neuroblastoma},
  url          = {http://dx.doi.org/10.1002/ijc.21888},
  volume       = {119},
  year         = {2006},
}

Chicago
Hoebeeck, Jasmien, Jo Vandesompele, Helén Nisson, Katleen De Preter, Nadine Van Roy, Els De Smet, Nurten Yigit, et al. 2006. “The Von Hippel-Lindau Tumor Suppressor Gene Expression Level Has Prognostic Value in Neuroblastoma.” International Journal of Cancer 119 (3): 624–629.
APA
Hoebeeck, J., Vandesompele, J., Nisson, H., De Preter, K., Van Roy, N., De Smet, E., Yigit, N., et al. (2006). The von Hippel-Lindau tumor suppressor gene expression level has prognostic value in neuroblastoma. INTERNATIONAL JOURNAL OF CANCER, 119(3), 624–629.
Vancouver
1.
Hoebeeck J, Vandesompele J, Nisson H, De Preter K, Van Roy N, De Smet E, et al. The von Hippel-Lindau tumor suppressor gene expression level has prognostic value in neuroblastoma. INTERNATIONAL JOURNAL OF CANCER. 2006;119(3):624–9.
MLA
Hoebeeck, Jasmien, Jo Vandesompele, Helén Nisson, et al. “The Von Hippel-Lindau Tumor Suppressor Gene Expression Level Has Prognostic Value in Neuroblastoma.” INTERNATIONAL JOURNAL OF CANCER 119.3 (2006): 624–629. Print.